Epidural analgesia information sessions provided by anesthetic nurses: impact on satisfaction and anxiety of parturient women a prospective sequential study

Autor: Quentin Cherel, Julien Burey, Julien Rousset, Anne Picard, Dimitra Mirza, Christina Dias, Hélène Jacquet, Paule Mariani, Nathalie Raffegeau, Isabelle Saupin, Marie Bornes, Nathanaël Lapidus, Christophe Quesnel, Marc Garnier

Publikováno v: BMC Anesthesiology, Vol 22, Iss 1, Pp 1-10 (2022)

Abstract Background Information on epidural analgesia delivered to parturient women is frequently incomplete, making it difficult for expectant mothers to make an appropriate choice for their delivery. We assessed the impact of a multimodal informati

Externí odkaz: https://doaj.org/article/3c479b3d637048aeabeafa35c7635359

Microbiota, type 2 diabetes and non-alcoholic fatty liver disease: protocol of an observational study

Autor: Benedetta M. Motta, Christoph Grander, Martin Gögele, Luisa Foco, Vladimir Vukovic, Roberto Melotti, Christian Fuchsberger, Alessandro De Grandi, Chiara Cantaloni, Anne Picard, Deborah Mascalzoni, Alessandra Rossini, Cristian Pattaro, Herbert Tilg, Peter P. Pramstaller

Publikováno v: Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-12 (2019)

Abstract Background Non-alcoholic fatty liver disease (NAFLD) is characterized by triglyceride accumulation in the hepatocytes in the absence of alcohol overconsumption, commonly associated with insulin resistance and obesity. Both NAFLD and type 2 d

Externí odkaz: https://doaj.org/article/4d21067acc604e838bac1618f6fa51dc

Generation of an induced pluripotent stem cell line (EURACi005-A) from a Parkinson's disease patient carrying a homozygous exon 3 deletion in the PRKNgene

Autor: Alessandra Zanon, Diana Riekschnitz, Michael von Troyer, Claudia Volpato, Anne Picard, Chiara Cantaloni, Marina Di Segni, Rosamaria Silipigni, Peter P. Pramstaller, Andrew A. Hicks, Irene Pichler

Publikováno v: Stem Cell Research, Vol 41, Iss , Pp - (2019)

Mutations in the PRKN gene, encoding parkin, are the most frequent known cause of recessive Parkinson's disease (PD). We report the generation of an induced pluripotent stem cell (iPSC) line of a patient carrying a homozygous deletion of exon 3 in th

Externí odkaz: https://doaj.org/article/6cf15886ff144d749ebfaf6a1d5a1cee

Increased Levels of the Parkinson's Disease-Associated Gene ITPKB Correlate with Higher Expression Levels of alpha-Synuclein, Independent of Mutation Status

Autor: Francesca Di Leva, Michele Filosi, Lisa Oyston, Erica Silvestri, Anne Picard, Alexandros A. Lavdas, Evy Lobbestael, Veerle Baekelandt, G. Gregory Neely, Peter P. Pramstaller, Andrew A. Hicks, Corrado Corti

Publikováno v: International Journal of Molecular Sciences
Volume 24
Issue 3
Pages: 1984

Autosomal dominant mutations in the gene encoding α-synuclein (SNCA) were the first to be linked with hereditary Parkinson's disease (PD). Duplication and triplication of SNCA has been observed in PD patients, together with mutations at the N-termin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::049254d95e1f8b4767b7e576ec5d0b5f
https://lirias.kuleuven.be/handle/20.500.12942/714654

Exome-wide association study of levodopa-induced dyskinesia in Parkinson's disease

Autor: Irene Pichler, Francisco S. Domingues, Nicola Modugno, Alessandra Nicoletti, Alessandro Gialluisi, Mario Zappia, Grazia Annesi, Andrew A. Hicks, Peter P. Pramstaller, Teresa Esposito, Cristian Pattaro, Roberto Melotti, Christine Schwienbacher, Marina Ciullo, Hagen Blankenburg, Eva König, Anne Picard

Publikováno v: Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-6 (2021)
Scientific reports (Nature Publishing Group) 11 (2021). doi:10.1038/s41598-021-99393-8
info:cnr-pdr/source/autori:Konig E.; Nicoletti A.; Pattaro C.; Annesi G.; Melotti R.; Gialluisi A.; Schwienbacher C.; Picard A.; Blankenburg H.; Pichler I.; Modugno N.; Ciullo M.; Esposito T.; Domingues F.S.; Hicks A.A.; Zappia M.; Pramstaller P.P./titolo:Exome-wide association study of levodopa-induced dyskinesia in Parkinson's disease/doi:10.1038%2Fs41598-021-99393-8/rivista:Scientific reports (Nature Publishing Group)/anno:2021/pagina_da:/pagina_a:/intervallo_pagine:/volume:11

Levodopa is the standard long-term dopamine replacement therapy to treat Parkinson’s disease (PD) symptoms. With time, levodopa may induce debilitating dyskinesias (LID), the treatment of which represents a large clinically unmet need. However, tim

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f84bfd8365b9330701dacfd093a333fc
https://pubmed.ncbi.nlm.nih.gov/34599261